V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
MedTech & Diagnostics

Masimo Executive Compensation (FY24)

MASI · Executive and director compensation, fiscal 2022 to 2024
Data as of September 7, 2026Latest filing (8-K): April 30, 2025
270 figures on this page: 260 cited to the filing that reported them, 10 calculated from figures it prints. See the citations
Median of the other named officers
$7,179,060
5 officers, excluding the chief executive
Latest say-on-pay support
=
April 29, 2025
Chief executive pay ratio
◇
To the median employee
What changed from fiscal 2022 to fiscal 2024
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Joe Kiani: $16,219,278 → $15,932,345 (1.8% lower)
Say-on-pay support: 64.9% → 88.1% (23.2 points higher)

Frequently asked questions

Answers drawn from the data on this page.
What was Masimo's say-on-pay result?
For fiscal 2024, shareholders backed the say-on-pay proposal with 88.1% of votes cast for or against in favor at the meeting held April 29, 2025.
Which companies are in Masimo's peer group?
Companies named in the disclosed peer group include Align Technology, Inc., DENTSPLY SIRONA, Inc., Dexcom, Inc., Globus Medical, Inc. and Haemonetics Corp., among others.
What is Masimo's chief executive pay ratio?
The company reported a chief executive pay ratio of 163:1 for fiscal 2024, against median employee compensation of $82,544.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Joe Kiani
Chief Executive Officer Chairman of the Board
◇—◇◇◇—◇◇
Bilal Muhsin
Chief Operating Officer
◇—◇◇◇—◇◇
Tom McClenahan
Executive Vice President, General Counsel Corporate Secretary
◇—◇◇◇—◇◇
Micah Young
Executive Vice President, Chief Financial Officer
◇—◇◇◇—◇◇
Tao Levy
Executive Vice President, Business Development
◇—◇◇◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Joe Kiani
Former Chief Executive Officer and Chairman of the Board
Departed during or after this year
◇—◇◇——◇◇
Bilal Muhsin
Chief Operating Officer
◇—◇◇◇—◇◇
Micah Young
Executive Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Tom McClenahan
Executive Vice President, General Counsel and Corporate Secretary
◇—◇◇——◇◇
Blair Tripodi
Chief Operating Officer, Consumer Division
◇—◇◇◇—◇◇
Michelle Brennan
Former Interim Chief Executive Officer
Departed during or after this year
Served on an interim basis
◇—◇———◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2024
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Bilal MuhsinOPTION◇——◇—◇◇
Bilal MuhsinPSU◇◇◇—◇—◇
Bilal MuhsinRSU◇——◇——◇
Blair TripodiRSU◇——◇——◇
Blair TripodiOPTION◇——◇—◇◇
Blair TripodiPSU◇◇◇—◇—◇
Joe KianiOPTION◇——◇—◇◇
Joe KianiPSU◇◇◇—◇—◇
Micah YoungRSU◇——◇——◇
Micah YoungOPTION◇——◇—◇◇
Micah YoungPSU◇◇◇—◇—◇
Michelle BrennanRSU◇——◇——◇
Tom McClenahanRSU◇——◇——◇
Tom McClenahanOPTION◇——◇—◇◇
Tom McClenahanPSU◇◇◇—◇—◇
Fiscal 2022 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2024 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Blair TripodiRSU◇◇——
PSU◇◇——
Option◇—◇3/1/2034
Option◇—◇3/3/2033
RSU◇◇——
PSU◇◇——
PSU◇◇——
Bilal MuhsinPSU◇◇——
Option◇—◇2/26/2031
Option◇—◇3/02/2023
PSU◇◇——
Option◇—◇3/1/2034
Option◇—◇2/22/2032
RSU◇◇——
Option◇—◇3/12/2030
PSU◇◇——
Micah YoungPSU◇◇——
RSU◇◇——
PSU◇◇——
Option◇—◇3/2/2033
Option◇—◇2/26/2031
Option◇—◇2/22/2032
Option◇—◇3/12/2030
Option◇—◇3/1/2034
PSU◇◇——
Tom McClenahanOption◇—◇2/26/2031
PSU◇◇——
Option◇—◇3/2/2033
PSU◇◇——
Option◇—◇2/22/2032
PSU◇◇——
Option◇—◇3/12/2030
RSU◇◇——
Option◇—◇3/1/2034
Michelle BrennanRSU◇◇——
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2024
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Robert Chapek
◇◇————◇
Craig Reynolds
◇◇————◇
Quentin Koffey
◇◇————◇
Michelle Brennan
Board chair
◇◇————◇
William Jellison
◇◇————◇
Darlene Solomon
◇◇————◇
Timothy Scannell
◇◇————◇
Wendy Lane
◇◇————◇
Rolf Classon
◇—————◇
Adam Mikkelson
◇—————◇
Catherine Szyman served on the board in fiscal 2024 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Audit committee member◇
Compensation committee member◇

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2024
  • Align Technology, Inc. ALGN
  • DENTSPLY SIRONA, Inc. XRAY
  • Dexcom, Inc. DXCM
  • Globus Medical, Inc. GMED
  • Haemonetics Corp. HAE
  • Hologic, Inc. HOLX
  • ICU Medical, Inc. ICUI
  • Insulet Corporation PODD
  • Integra LifeSciences Holdings Corp. IART
  • LivaNova PLC LIVN
  • QuidelOrtho QDEL
  • ResMed RMD
  • Teladoc Health, Inc. TDOC
  • Teleflex, Inc. TFX
  • The Cooper Companies COO

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2024April 29, 2025=◇◇◇
2023September 19, 2024=◇◇◇
2022June 26, 2023=◇◇◇
2021May 26, 2022=◇◇◇
2020May 27, 2021=◇◇◇
2019May 29, 2020=◇◇◇
2018May 30, 2019=◇◇◇
2017May 31, 2018=◇◇◇
2016June 1, 2017=◇◇◇
2015April 20, 2016=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Masimo files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Masimo disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Masimo sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Enquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether Masimo's disclosed peer group is defensible, who names Masimo back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
270 figures on this page: 260 cited to the filing that reported them, 10 calculated from figures it prints.
260 cited to the filing
10 calculated from the filing

Documents cited

  1. 0001104659-25-042485
  2. 0001104659-25-027887
    CEO Pay Ratio · Fiscal 2024 Non-Employee Director Compensation Table · GRANTS OF PLAN-BASED AWARDS DURING FISCAL YEAR 2024 · Grants of Plan-Based Awards During Fiscal Year 2024 · and 4 more sections
  3. 0000937556-24-000085
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0000937556-23-000172
    Item 5.07 Submission of Matters to a Vote of Security Holders
  5. 0000937556-22-000107
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0000937556-21-000105
    Item 5.07 Submission of Matters to a Vote of Security Holders
  7. 0000937556-20-000119
    Item 5.07 Submission of Matters to a Vote of Security Holders
  8. 0000937556-19-000112
  9. 0000937556-18-000102
    Item 5.07 Submission of Matters to a Vote of Security Holders
  10. 0000937556-17-000132
    Item 5.07 Submission of Matters to a Vote of Security Holders
  11. 0000937556-16-000263
    Item 5.07 Submission of Matters to a Vote of Security Holders
  12. 0000937556-22-000074
    SUMMARY COMPENSATION TABLE
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Masimo executive compensation, FY2022–FY2024.” https://intel.velarion.ai/comp/MASI (accessed 2026).
Short form: data: Velarion
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Masimo and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers Masimo discloses

The companies named in MASI's own disclosed peer group.

Align Technology, Inc.DENTSPLY SIRONA, Inc.Dexcom, Inc.Globus Medical, Inc.Haemonetics Corp.Hologic, Inc.ICU Medical, Inc.Insulet CorporationIntegra LifeSciences Holdings Corp.LivaNova PLCResMedTeleflex, Inc.The Cooper Companies

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  The Pay Desk · Methodology · Terms · Privacy